Allogeneic Blood or Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis for Myelodysplastic Syndrome/Myeloproliferative Neoplasm-Overlap Syndromes (MDS/MPN)

被引：0
|
作者：
Karantanos, Theodoros
Tsai, Hua-Ling
Gondek, Lukasz P.
Levis, Mark
Showel, Margaret M.
DeZern, Amy E.
Gojo, Ivana
Varadhan, Ravi
Jones, Richard J.
Jain, Tania
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Post-Transplantation Cyclophosphamide and Mesenchymal Stem Cells Infusion For Graft-Versus-Host Prophylaxis For Patients With Advanced Disease After Allogenic Bone Marrow Transplantation
    Drokov, Mikhail
    Parovichnikova, Elena
    Kuzmina, Larisa
    Vasilyeva, Vera
    Karyakina, Alexandra
    Galstian, Gennadyi
    Savchenko, Valeri G.
    BLOOD, 2013, 122 (21)
  • [22] Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
    Yao, Janny M.
    Otoukesh, Salman
    Kim, Hanna
    Yang, Dongyun
    Mokhtari, Sally
    Samara, Yazeed
    Blackmon, Amanda
    Arslan, Shukaib
    Agrawal, Vaibhav
    Pourhassan, Hoda
    Amanam, Idoroenyi
    Ball, Brian
    Koller, Paul
    Salhotra, Amandeep
    Becker, Pamela
    Curtin, Peter
    Artz, Andrew
    Aldoss, Ibrahim
    Ali, Haris
    Stewart, Forrest
    Smith, Eileen
    Stein, Anthony
    Marcucci, Guido
    Forman, Stephen J.
    Nakamura, Ryotaro
    Al Malki, Monzr M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (08): : 515e1 - 515e7
  • [23] Immunophenotyping and Function of Peripheral Blood Mononuclear Cells in Patients Undergoing Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide in Combination with ATG Anti-Graft Versus Host Disease Prophylaxis
    Beider, Katia
    Voevoda, Valeria
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Danilesko, Ivetta
    Grushchenko-Polaq, Ania Hava
    Devillers, Olivia
    Wolf, Idit
    Ostrovsky, Olga
    Shimoni, Avichai
    Nagler, Arnon
    BLOOD, 2019, 134
  • [24] PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION (BMT) APPEARS TO ABROGATE THE ANTILEUKEMIC IMMUNOLOGICAL SURVEILLANCE OF THE MARROW GRAFT
    HENSLEE, PJ
    THOMPSON, JS
    ROMOND, EH
    DOUKAS, M
    MESSINO, M
    MACDONALD, JS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 108 - 108
  • [25] Allogeneic bone marrow transplantation (allo BMT): Role of T cell depletion (TCD) and graft versus host disease (GVHD).
    Huff, CA
    Noga, SJ
    Jones, RJ
    Vogelsang, GB
    Fuchs, EJ
    Marcellus, D
    BLOOD, 2000, 96 (11) : 202A - 202A
  • [26] Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
    Lin, Andrew
    Flynn, Jessica
    DeRespiris, Lauren
    Figgins, Bradley
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony
    Devlin, Sean M.
    Cho, Christina
    Tamari, Roni
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Seo, Susan K.
    Shaffer, Brian
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):
  • [27] Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
    Elmariah, Hany
    Otoukesh, Salman
    Kumar, Ambuj
    Ali, Haris
    Arslan, Shukaib
    Shouse, Geoffrey
    Pourhassan, Hoda
    Nishihori, Taiga
    Faramand, Rawan
    Mishra, Asmita
    Khimani, Farhad
    Fernandez, Hugo
    Lazaryan, Aleksandr
    Nieder, Michael
    Perez, Lia
    Liu, Hien
    Nakamura, Ryotaro
    Pidala, Joseph
    Marcucci, Guido
    Forman, Stephen J.
    Anasetti, Claudio
    Locke, Frederick
    Bejanyan, Nelli
    Malki, Monzr M. Al
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : e1 - e11
  • [28] Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
    Jullien, Maxime
    Orvain, Corentin
    Berceanu, Ana
    Couturier, Marie-Anne
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Le Bourgeois, Amandine
    Klemencie, Marion
    Schmidt, Aline
    Hunault, Mathilde
    Daguindau, Etienne
    Roussel, Xavier
    Delepine, Pascal
    Guillerm, Gaelle
    Giltat, Aurelien
    Francois, Sylvie
    Thepot, Sylvain
    Le Gouill, Steven
    Bene, Marie-C
    Chevallier, Patrice
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 861.e1 - 861.e7
  • [29] A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
    Morozova, Elena Vladislavovna
    Barabanshikova, Maria Vladimirovna
    Moiseev, Ivan Sergeevich
    Shakirova, Alena Igorevna
    Barhatov, Ildar Munerovich
    Ushal, Inna Edvardovna
    Rodionov, Gennadij Georgievich
    Moiseev, Sergey Ivanovich
    Surkova, Elena Arkadjevna
    Lapin, Sergey Vladimirovich
    Vlasova, Julia Jurjevna
    Rudakova, Tatjana Alexandrovna
    Darskaya, Elena Igorevna
    Baykov, Vadim Valentinovich
    Alyanski, Alksandr Leonidovich
    Bondarenko, Sergey Nikolaevich
    Afanasyev, Boris Vladimirovich
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 158 - 165
  • [30] Prophylaxis of graft-versus-host disease (GVHD) with tacrolimus and methotrexate after allogeneic bone marrow transplantation (BMT) from unrelated donor: Impact of blood level of tacrolimus on the development of acute GVHD
    Mori, T
    Nakazato, T
    Aisa, Y
    Yamazaki, R
    Ikeda, Y
    Okamoto, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 65 - 65
12345